donepezil + tandospirone

Donepezil + tandospirone is a combination therapy consisting of two small molecule drugs, donepezil and tandospirone. Donepezil is an acetylcholinesterase inhibitor primarily used to treat cognitive symptoms in Alzheimer's disease by increasing acetylcholine levels in the brain, thereby improving memory and cognition. Tandospirone is an anxiolytic and antidepressant of the azapirone class that acts as a selective partial agonist at the serotonin 5-HT1A receptor, with additional weak activity at other receptors. The combination has been studied for its potential to improve both cognitive function and neuropsychiatric symptoms (such as anxiety) in patients with Alzheimer's disease who present with comorbid anxiety or behavioral disturbances[6][1]. Clinical studies suggest that while both agents may improve cognition, the addition of tandospirone provides significant benefit for anxiety symptoms and behavioral disturbances compared to donepezil alone[6].